扩大放疗野至腹主动脉旁淋巴结能否降低晚期宫颈癌远处转移风险?随机临床试验的系统综述与Meta分析
结果显示扩大放疗野显著降低腹主动脉旁淋巴结失败率(HR 0.35,95%CI 0.19-0.64;p<0.01)及其他远处转移发生率(HR 0.69,95%CI 0.50-0.96;p=0.03),但局部区域失败和癌症相关死亡无显著改变。结论认为扩大放疗野可减少远处转移事件,但对生存的影响尚不明确。
要点
- 扩大放疗野至腹主动脉旁淋巴结显著降低腹主动脉旁淋巴结失败率(HR 0.35,95%CI 0.19-0.64;p<0.01)。
- 扩大放疗野显著降低其他远处转移发生率(HR 0.69,95%CI 0.50-0.96;p=0.03)。
- 局部区域失败和癌症相关死亡无显著改变,对生存的影响尚不明确。
核心结论
- 扩大放疗野至腹主动脉旁淋巴结可减少远处转移事件,但其对生存的影响尚不明确。
- 未来研究应评估采用现代放疗技术的扩大放疗野的价值。
研究设计与样本
- 系统检索PubMed、CENTRAL、Clinical Trials数据库,纳入1960年至2015年11月发表的随机临床试验,无语言限制。
- 两组患者均接受盆腔放疗和相同的全身治疗;主要终点为局部区域失败、远处转移发生率、腹主动脉旁淋巴结失败和癌症相关死亡。
- 采用Mantel-Haenszel法进行Meta分析,使用Cochrane手册V5.1.0的7域法评估偏倚风险。
主要发现
- 扩大放疗野至腹主动脉旁淋巴结显著降低腹主动脉旁淋巴结失败率(HR 0.35,95%CI 0.19-0.64;p<0.01)。
- 扩大放疗野显著降低其他远处转移发生率(HR 0.69,95%CI 0.50-0.96;p=0.03)。
- 局部区域失败无显著改变(OR 1.06,95%CI 0.80-1.42;p=0.67)。
- 癌症相关死亡无显著改变(OR 0.68,95%CI 0.45-1.01;p=0.06)。
- 治疗相关死亡共10例:盆腔放疗组4例,扩大放疗野组6例(OR 2.12,95%CI 0.71-6.27;p=0.18)。
关键数值与推荐
- 纳入标准:随机临床试验;两组均接受盆腔放疗和相同的全身治疗;发表时间1960年至2015年11月。
- 主要终点:局部区域失败、远处转移发生率、腹主动脉旁淋巴结失败、癌症相关死亡。
- 偏倚风险:近80%的域评为低风险。
- 放疗技术:3项研究采用常规技术,1项研究采用适形技术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 扩大放疗野至腹主动脉旁淋巴结对生存的影响尚不明确。
- 未来研究应评估采用现代放疗技术的扩大放疗野的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the impact of the extension of the radiotherapy field cranially toward para-aortic lymph nodes (EF-RT) in advanced cervical cancer. MATERIALS AND METHODS: A systematic search of databases (PubMed, CENTRAL, Clinical Trials) was performed and included studies that were published between 1960 and November 2015 without language restrictions. All randomized clinical trials (RCTs) were analyzed further. All patients must have undergone pelvic radiotherapy and the same systemic therapy in both arms. The primary endpoints were locoregional failure, incidence of distant metastasis, para-aortic failure, and cancer related death. The Mantel-Haenszel method was used in the meta-analysis. The risk of bias analysis was determined using the 7-domain method per the Cochrane Handbook for Systematic Reviews of Interventions V5.1.0. A review of the treatment technique and toxicity was also performed. RESULTS: A total of 1309 studies were evaluated, 4 RCTs of which met the inclusion criteria; 506 patients were allocated to standard pelvic irradiation, and 494 underwent EF-RT. The risk of bias was considered to be low in nearly 80% of the domains. EF-RT significantly reduced the rate of para-aortic failure (HR 0.35, 95% CI 0.19-0.64; p<0.01) and the incidence of other distant metastases (HR 0.69, 95% CI 0.50-0.96; p=0.03). Locoregional failure and cancer-related death were not significantly altered (OR 1.06 [0.80-1.42]; p=0.67, and 0.68 [0.45-1.01]; p=0.06, respectively). The radiotherapy technique was conventional in 3 studies and conformational in 1 study. In total, 10 treatment-related deaths occurred-4 in pelvic radiation and 6 in EF-RT (OR 2.12 [0.71-6.27]; p=0.18). CONCLUSIONS: EF-RT that targets the para-aortic lymphatic chain reduces distant metastatic events, but its impact on survival is unknown. Future studies should examine the value of EF-RT using modern radiation techniques.
引用
- Sapienza LG, Gomes MJL, Calsavara VF, et al. Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials. Gynecol Oncol. 2016. PMID: 27908530. doi:10.1016/j.ygyno.2016.11.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。